Global Drugs & Biologics Update
February 24, 2015
Latin America |
| Brazil |
Anvisa - National Health Surveillance Agency |
| Recalls/Suspensions |
Sale and use of Policlavumoxil suspended |
Anvisa has suspended the manufacture, distribution, sale and use of Policlavumoxil 250mg / 5ML + 62.5 mg / 5ML powder for oral suspension manufactured by EMS S / AA. The measure applies to all lots of this product. |
| Close this Window |